Development of a targeted drug delivery system is a critical step in the effort to improve cancer treatments. Such a system would greatly reduce the harmful side effects of chemotherapy by delivering toxic drugs directly to cancerous cells. Peptoids—synthetic compounds that can be easily produced from readily available amine monomers—have great potential for use in targeted drug delivery. This project aimed to develop peptoids that would bind to specific proteins expressed on the surface of cancer cells. These peptoids could be combined into a complex that would bind to the proteins with an even greater affinity than the individual compounds. The peptoid complexes would serve as a targeting system for chemotherapeutic drugs, delivering them...
Efficient delivery into cells is essential for many applications. However, cellular access of “cell...
We describe the use of bioactive peptides to drive liposomal drugs on target receptors overexpressed...
Doctor of PhilosophyDepartment of ChemistryStefan H. BossmannCancer is not only the second leading c...
<div><p>Cationic, amphipathic host defense peptides represent a promising group of agents to be deve...
Cancer is a disease that has plagued scientists for decades, and how to treat cancer and its complic...
Peptide-based therapeutics have been an active area of research for a number of years. They have bee...
Cancer is the second leading cause of death worldwide and the lack of alternative therapies has kept...
According to the World Health Organization (WHO), Cancer is the leading cause of death worldwide, ac...
Mitochondria-specific delivery methods offer a valuable tool for studying mitochondria-related disea...
Doctor of PhilosophyDepartment of ChemistryStefan H. BossmannThis paper describes two methods for ut...
A summary of the current status of the application of peptidomimetics in cancer therapeutics as an a...
This paper describes two methods for utilizing cancer associated proteases for targeting cancer ther...
Using peptide sequences for the design of functional peptoids is demonstrated for a peptide based fo...
Cancer is a complex family of diseases. As our understanding of cancer biology has improved, so has ...
In the development of anti-cancer drugs, it is important to maintain selective toxicity towards tumo...
Efficient delivery into cells is essential for many applications. However, cellular access of “cell...
We describe the use of bioactive peptides to drive liposomal drugs on target receptors overexpressed...
Doctor of PhilosophyDepartment of ChemistryStefan H. BossmannCancer is not only the second leading c...
<div><p>Cationic, amphipathic host defense peptides represent a promising group of agents to be deve...
Cancer is a disease that has plagued scientists for decades, and how to treat cancer and its complic...
Peptide-based therapeutics have been an active area of research for a number of years. They have bee...
Cancer is the second leading cause of death worldwide and the lack of alternative therapies has kept...
According to the World Health Organization (WHO), Cancer is the leading cause of death worldwide, ac...
Mitochondria-specific delivery methods offer a valuable tool for studying mitochondria-related disea...
Doctor of PhilosophyDepartment of ChemistryStefan H. BossmannThis paper describes two methods for ut...
A summary of the current status of the application of peptidomimetics in cancer therapeutics as an a...
This paper describes two methods for utilizing cancer associated proteases for targeting cancer ther...
Using peptide sequences for the design of functional peptoids is demonstrated for a peptide based fo...
Cancer is a complex family of diseases. As our understanding of cancer biology has improved, so has ...
In the development of anti-cancer drugs, it is important to maintain selective toxicity towards tumo...
Efficient delivery into cells is essential for many applications. However, cellular access of “cell...
We describe the use of bioactive peptides to drive liposomal drugs on target receptors overexpressed...
Doctor of PhilosophyDepartment of ChemistryStefan H. BossmannCancer is not only the second leading c...